Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devon S Conway

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis and Related Disorders|June 6, 2025
De-escalation of disease modifying therapies: A retrospective, observational single center studyCarolyn Goldschmidt, Jordan Glassman, Brandon Ly, et al.
Multiple Sclerosis and Related Disorders|December 12, 2024
Body mass index trends over four years in persons with multiple sclerosisDevon S Conway, Karlo Toljan, Kathleen A Harris, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2018
Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?Devon S Conway, Maria Cecilia Vieira, Nicolas R Thompson, et al.
Multiple Sclerosis and Related Disorders|December 1, 2020
Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis PatientsDevon S Conway, Sarah M Planchon, Se Hong Oh, et al.
The Patient|January 7, 2026
Patient Preferences for Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatments: Results from a Discrete Choice Experiment Study in the USAJustin R Abbatemarco, Adrian Kielhorn, Jeffrey C Yu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2024
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White AmericansFarren Bs Briggs, Devon S Conway, Carrie M Hersh, et al.
International Journal of MS Care|January 12, 2024
Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple SclerosisFarren B S Briggs, Erika S Trapl, Farrah J Mateen, et al.
Multiple Sclerosis and Related Disorders|December 10, 2020
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patientsJustin R Abbatemarco, Daniel Ontaneda, Kunio Nakamura, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 23, 2024
Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosisMina M Huerta, Devon S Conway, Sarah M Planchon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 13, 2014
Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical databaseDeborah M Miller, Nicolas R Thompson, Jeffrey A Cohen, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis and Related Disorders|June 6, 2025
De-escalation of disease modifying therapies: A retrospective, observational single center studyCarolyn Goldschmidt, Jordan Glassman, Brandon Ly, et al.
Multiple Sclerosis and Related Disorders|December 12, 2024
Body mass index trends over four years in persons with multiple sclerosisDevon S Conway, Karlo Toljan, Kathleen A Harris, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 2, 2018
Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?Devon S Conway, Maria Cecilia Vieira, Nicolas R Thompson, et al.
Multiple Sclerosis and Related Disorders|December 1, 2020
Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis PatientsDevon S Conway, Sarah M Planchon, Se Hong Oh, et al.
The Patient|January 7, 2026
Patient Preferences for Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatments: Results from a Discrete Choice Experiment Study in the USAJustin R Abbatemarco, Adrian Kielhorn, Jeffrey C Yu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2024
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White AmericansFarren Bs Briggs, Devon S Conway, Carrie M Hersh, et al.
International Journal of MS Care|January 12, 2024
Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple SclerosisFarren B S Briggs, Erika S Trapl, Farrah J Mateen, et al.
Multiple Sclerosis and Related Disorders|December 10, 2020
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patientsJustin R Abbatemarco, Daniel Ontaneda, Kunio Nakamura, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 23, 2024
Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosisMina M Huerta, Devon S Conway, Sarah M Planchon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 13, 2014
Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical databaseDeborah M Miller, Nicolas R Thompson, Jeffrey A Cohen, et al.
Pageof 6